Amylyx Pharmaceuticals

-$0.20 (-2.32%) As of 6:24 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMLX and other ETFs, options, and stocks.

About AMLX

Amylyx Pharmaceuticals, Inc. operates as a biopharmaceutical company, which provides disease-modifying solutions for neurodegenerative diseases. The firm focuses on streamlined clinical development and drug discovery.

CEO
Joshua B. Cohen
Employees
205
Headquarters
Cambridge, Massachusetts
Founded
2013

AMLX Key Statistics

Market cap
497.45M
Price-Earnings ratio
—
Dividend yield
—
Average volume
215.22K
High today
$8.42
Low today
$8.14
Open price
$8.36
Volume
77.31K
52 Week high
$33.41
52 Week low
$6.51

AMLX Earnings

-$0.93
-$0.62
-$0.31
-$0.00
Q1 FY22
Estimated
— per share
Actual
-$0.93 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure